期刊论文详细信息
BMC Medical Education
Preparing pharmacists to deliver a targeted service in hypertension management: evaluation of an interprofessional training program
Carol L. Armour3  Ines Krass1  Christopher Roberts4  Parker J. Magin5  Kate S. Lemay3  Beata V. Bajorek2 
[1]Faculty of Pharmacy, University of Sydney (USyd), Sydney, Australia
[2]Graduate School of Health, University of Technology Sydney (UTS), Sydney, Australia
[3]Woolcock Institute of Medical Research, University of Sydney (USyd), Sydney, Australia
[4]Sydney Medical School - Northern, Hornsby Ku-ring-Gai Hospital, Sydney, Australia
[5]Discipline of General Practice, University of Newcastle (UNewc), Newcastle, Australia
关键词: Adherence;    Interprofessional;    Training;    Prescribing;    Pharmacist;    Hypertension;   
Others  :  1228684
DOI  :  10.1186/s12909-015-0434-y
 received in 2014-10-27, accepted in 2015-09-07,  发布年份 2015
PDF
【 摘 要 】

Background

Non-adherence to medicines by patients and suboptimal prescribing by clinicians underpin poor blood pressure (BP) control in hypertension. In this study, a training program was designed to enable community pharmacists to deliver a service in hypertension management targeting therapeutic adjustments and medication adherence. A comprehensive evaluation of the training program was undertaken.

Methods

Tailored training comprising a self-directed pre-work manual, practical workshop (using real patients), and practice scenarios, was developed and delivered by an inter-professional team (pharmacists, GPs). Supported by practical and written assessment, the training focused on the principles of BP management, BP measurement skills, and adherence strategies. Pharmacists’ experience of the training (expectations, content, format, relevance) was evaluated quantitatively and qualitatively. Immediate feedback was obtained via a questionnaire comprising Likert scales (1 = “very well” to 7 = “poor”) and open-ended questions. Further in-depth qualitative evaluation was undertaken via semi-structured interviews several months post-training (and post service implementation).

Results

Seventeen pharmacists were recruited, trained and assessed as competent. All were highly satisfied with the training; other than the ‘amount of information provided’ (median score = 5, “just right”), all aspects of training attained the most positive score of ‘1’. Pharmacists most valued the integrated team-based approach, GP involvement, and inclusion of real patients, as well as the pre-reading manual, BP measurement workshop, and case studies (simulation). Post-implementation the interviews highlighted that comprehensive training increased pharmacists’ confidence in providing the service, however, training of other pharmacy staff and patient recruitment strategies were highlighted as a need in future.

Conclusions

Structured, multi-modal training involving simulated and inter-professional learning is effective in preparing selected community pharmacists for the implementation of new services in the context of hypertension management. This training could be further enhanced to prepare pharmacists for the challenges encountered in implementing and evaluating services in practice.

【 授权许可】

   
2015 Bajorek et al.

【 预 览 】
附件列表
Files Size Format View
20151018021319993.pdf 737KB PDF download
Fig. 2. 55KB Image download
Fig. 1. 71KB Image download
【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】
  • [1]Australian Government Department of Health: What is Cardiovascular disease? 2013 http://webarchive.nla.gov.au/gov/20140212210748/http://www.health.gov.au/internet/main/publishing.nsf/Content/Home. Accessed 23 Sept. 2015.
  • [2]Australian Government Department of Health: Chronic Disease. 2012 http://webarchive.nla.gov.au/gov/20140212210748/http://www.health.gov.au/internet/main/publishing.nsf/Content/Home. Accessed 23 Sept 2015.
  • [3]Carrington M, Jain A, Stewart S. Pressure points in primary care: a study of blood pressure in 532,050 patients in Australian from 2005 to 2010. Baker IDI Heart and Diabetes Institute, Melbourne, Australia; 2012.
  • [4]Janus E, Bunker S, Kilkkinen A, Mc Namara K, Philpot B, Tideman P, Tirimacco R, Laatikainen T, Heistaro S, Dunbar J. Prevalence, detection and drug treatment of hypertension in a rural Australian population: the Greater Green Triangle risk factor study 2004 – 2006. Intern Med J. 2008; 38(12):879-886.
  • [5]Webster R, Heeley E, Peiris D, Bayram C, Cass A, Patel A. Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust. 2009; 191(6):324-329.
  • [6]Howes F, Hansen E, Williams D, Nelson M. Barriers to diagnosing and managing hypertension. A qualitative study in Australian general practice. Aust Fam Physician. 2010; 39(7):511-516.
  • [7]Harris M, Lloyd J, Krastev Y, Fanaian M, Powell Davis G, Zwar N, Liaw S-T. Routine use of clinical management guidelines in Australian general practice. Austr J Prim Health. 2014; 20:41-46.
  • [8]Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004-2006. Med J Aust. 2008; 188(4):224-227.
  • [9]Nelson MR, Reid CM, Ryan P, Willson K, Yelland L. Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2). Med J Aust. 2006; 185(9):487-489.
  • [10]Castelino RL, Bajorek BV, Chen TF. Targeting Suboptimal Prescribing in the Elderly: A Review of the Impact of Pharmacy Services. Ann Pharmacother. 2009; 43(6):1096-1106.
  • [11]Castelino RL, Bajorek BV, Chen TF. Retrospective Evaluation of Home Medicines Review by Pharmacists in Older Australian Patients Using the Medication Appropriateness Index. Ann Pharmacother. 2010; 44(12):1922-1929.
  • [12]Machado M, Bajcar J, Guzzo G, Einarson T. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic reviews and meta-analysis in hypertension management. Ann Pharmacother. 2007; 41(11):1770-1781.
  • [13]Castelino RL, Chen TF, Guddattu V, Bajorek BV. Use of Evidence-Based Therapy for the Prevention of Cardiovascular Events Among Older people. Eval Health Professions. 2010; 33(3):276-301.
  • [14]Krass I, Bajorek B. Pharmacists’ therapeutic recommendations in the management of hypertension in primary care. National Medicines Symposium, Sydney (Australia); 2012.
  • [15]Svarstad B, Bultman D. Remington: the science and practice of pharmacy. The patient: behavioral determinants. Lippincott Williams & Wilkins, Baltimore; 2000.
  • [16]Armour CL, Lemay K, Saini B, Reddel HK, Bosnic-Anticevich SZ, Smith LD, Burton D, Song YJ, Alles MC, Stewart K et al.. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. J Asthma. 2011; 48(9):914-922.
  • [17]Community Pharmacy Roadmap Program Development: Pharmacist Prescribing – Protocol Driven. http://www.guild.org.au/docs/default-source/public-documents/tab—the-guild/Strategic-Direction/pharmacist-prescribingpdf?sfvrsn=0 accessed 040814.
  • [18]Clark D. Bloom’s taxonomy of learning domains: the three domains of learning. 2014 http://www.nwlink.com/~donclark/hrd/bloom.html (accessed 04/08/14) 1999
  • [19]National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee): Guide to Management of Hypertension 2008 (Updated December 2010). ISBN: 978-1-921226-85-4. www.heartfoundation.org.au Accessed November 2014.
  • [20]National Heart Foundation of Australia (Aslani P KI, Bajorek B, Thistlewaite J, Tofler G on behalf of the Heart Foundation Pharmaceutical Roundtable). Improving adherence in cardiovascular care. A toolkit for health professionals. 2011. http://www.heartfoundation.org.au/SiteCollectionDocuments/Improving-adherence-in-cardiovascular-care-toolkitpdf. Accessed 04 Aug 2014.
  • [21]Aziz Z, Jet C, Rahman C. Continuing Professional Development: views and barriers toward participation among Malaysian Pharmacists. Eur J Soc Behav Sci 2012. http://dx.doi.org/10.15405/FutureAcademy/ejsbs(2301-2218).2012.4.6. Accessed 04 Aug 2014.
  • [22]Tofade T, Chou S, Foushee L, Caiola S, Eckel S. Continuing professional development training program among pharmacist preceptors and nonpreceptors. J Am Pharm Assoc. 2003; 2010(50):730-735.
  • [23]Smithburger P, Kane-Gill S, Kloet M, Lohr B, Seybert A. Advancing interprofessional education through the use of high fidelity human patient simulators. Pharm Pract. 2013; 11(2):61-65.
  • [24]Vyas D, Ottis E, Caligiuri F. Teaching clinical reasoning and problem-solving skills using human patient simulation. Am J Pharm Educ. 2011; 75:189.
  • [25]Seybert A, Barton C. Simulation-based learning to teach blood pressure assessment to doctor of pharmacy students. Am J Pharm Educ. 2007; 71:48.
  • [26]Herbert C. Changing the culture: Interprofessional education for collaborative patient-centred practice in Canada. J Interprofession Care. 2005; May Supplement 1:1-4.
  • [27]Gilbert J. Leadership Perspectives. Interprofessional Education for Collaborative, Patient-Centred Practice. Nursing Leadership. 2005;18(2):32-38.
  • [28]Buring S, Bhushan A, Broeseker A, Conway S, Duncan-Hewitt W, Hansen L, Westberg S. Interprofessional Education: Definitions, Student Competencies, and Guidelines for Implementation. Am J Pharm Educ. 2009; 73(4):59.
  • [29]Dunston R. Implementation case study for online quality use of medicines modules. Interprofessional education for quality use of medicines. http://www.aippen.net/docs/CS8_UniNewcastle_QUM.pdf accessed 04/08/14.
  • [30]Hughes C, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003; 53(493):600-606.
  • [31]American Association of Colleges of Pharmacy and National Community Pharmacists Association (NCPA). Innovative medication adherence educators challenge: summary of submissions. 2012 http://www.ncpanet.org/pdf/adherence/SummaryofSumisssions_formatted_Final.pdf accessed 040814.
  • [32]Broersa S, Smetsa E, Bindelsb P, Bennebroek Evertsz’a F, Calffa M, de Haes H. Training general practitioners in behavior change counseling to improve asthma medication adherence. Patient Educ Couns. 2005; 58(3):279-287.
  • [33]Royal Pharmaceutical Society. Research ready - an introduction. https://www.rpharms.com/science-and-research-pdfs/research-ready-an-introduction.pdf. Accessed 04 Aug 2014.
  文献评价指标  
  下载次数:19次 浏览次数:20次